Moberg Pharma AB (SEK)
MOB
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range43.25 | 45.05
52-Wk Range |
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINSE0013121340
Volume70,003
Exchange VenueSTO

Company Profile

Moberg Pharma AB is a pharmaceutical company. The company develops and markets consumer healthcare products that relieve pain and treat skin conditions, mainly nail fungus.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)15.42
EPS Growth (3 year avg)-0.14
Operating Margin % 12.47
Net Margin %4.52
Return on Equity3.46
Debt/Equity1.00

Legal Documents

Annual Report
en 31/12/2018

Financials

Income Statement
SEK201320142015201620172018
Revenue (m)157200286334439439
Operating Income (m)-141230153455
Net Income (m)-111226331120
Basic EPS-1.010.961.802.270.641.14
Avg. Diluted Shares Outstanding (m)111314151817
Balance Sheet
SEK201320142015201620172018
Current Assets (m)59117119221233212
Non Current Assets (m)2122422781,0119901,040
Total Assets (m)2723603971,2321,2231,252
Current Liabilities (m)525345757456
Total Liabilities (m)------
Total Equity (m)201304353562552594
Cash Flows
SEK201320142015201620172018
Operating Cash Flows (m)-31631-185474
Capital Expenditure (m)-31-7-44-681-20-84
Figures are quoted in SEK unless stated otherwise
44.20
Last Price